Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-30 @ 9:15 AM
Study NCT ID:
NCT03370133
Status:
COMPLETED
Last Update Posted:
2025-12-23
First Post:
2017-12-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-07
First Submit QC Date:
None
Study First Post Date:
2017-12-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-01-05
Results First Submit QC Date:
None
Results First Post Date:
2022-02-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-01-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED